Literature DB >> 21718447

Surgical option for the correction of Peyronie's disease: an autologous tissue-engineered endothelialized graft.

Annie Imbeault1, Geneviève Bernard, Gabrielle Ouellet, Sara Bouhout, Serge Carrier, Stéphane Bolduc.   

Abstract

INTRODUCTION: Surgical treatment is indicated in severe cases of Peyronie's disease. Incision of the plaque with subsequent graft material implantation is the option of choice. Ideal graft tissue is not yet available. AIM: To evaluate the use of an autologous tissue-engineered endothelialized graft by the self-assembly method, for tunica albuginea (TA) reconstruction in Peyronie's disease.
METHODS: Two TA models were created. Human fibroblasts were isolated from a skin biopsy and cultured in vitro until formation of fibroblast sheets. After 4 weeks of maturation, human umbilical vein endothelial cells (HUVEC) were seeded on fibroblasts sheets and wrapped around a tubular support to form a cylinder of about 10 layers. After 21 days of tube maturation, HUVEC were seeded into the lumen of the fibroblast tubes for the endothelialized tunica albuginea (ETA). No HUVEC were seeded into the lumen for the TA model. Both constructs were placed under perfusion in a bioreactor for 1 week. MAIN OUTCOME MEASURES: Histology, immunohistochemistry, and burst pressure were performed to characterize mature tubular graft. Animal manipulations were also performed to demonstrate the impact of endothelial cells in vivo.
RESULTS: Histology showed uniform multilayered fibroblasts. Extracellular matrix, produced entirely by fibroblasts, presented a good staining for collagen 1. Some elastin fibers were also present. For the TA model, anti-human von Willebrand antibody revealed the endothelial cells forming capillary-like structures. TA model reached a burst pressure of 584 mm Hg and ETA model obtained a burst pressure of 719 mm Hg.
CONCLUSIONS: This tissue-engineered endothelialized tubular graft is structurally similar to normal TA and presents an adequate mechanical resistance. The self-assembly method used and the autologous property of this model could represent an advantage comparatively to other available grafts. Further evaluation including functional testing will be necessary to characterize in vivo implantation and behavior of the graft.
© 2011 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21718447     DOI: 10.1111/j.1743-6109.2011.02374.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  13 in total

Review 1.  Surgical management of Peyronie's disease.

Authors:  Uwais B Zaid; Amjad Alwaal; Xiaoyu Zhang; Tom F Lue
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

Review 2.  Update on medical management of Peyronie's disease.

Authors:  Ronny B W Tan; Premsant Sangkum; Gregory C Mitchell; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

Review 3.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

4.  Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.

Authors:  Fabio Castiglione; Petter Hedlund; Frank Van der Aa; Trinity J Bivalacqua; Patrizio Rigatti; Hein Van Poppel; Francesco Montorsi; Dirk De Ridder; Maarten Albersen
Journal:  Eur Urol       Date:  2012-09-24       Impact factor: 20.096

5.  An endothelialized urothelial cell-seeded tubular graft for urethral replacement.

Authors:  Annie Imbeault; Geneviève Bernard; Alexandre Rousseau; Amélie Morissette; Stéphane Chabaud; Sara Bouhout; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

Review 6.  Surgery for Peyronie's disease.

Authors:  Laurence A Levine; Stephen M Larsen
Journal:  Asian J Androl       Date:  2012-11-26       Impact factor: 3.285

Review 7.  Towards clinical application of tissue engineering for erectile penile regeneration.

Authors:  Tom W Andrew; Muholan Kanapathy; Log Murugesan; Asif Muneer; Deepak Kalaskar; Anthony Atala
Journal:  Nat Rev Urol       Date:  2019-10-24       Impact factor: 14.432

8.  Surgical Management for Peyronie's Disease.

Authors:  Robert L Segal; Arthur L Burnett
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

Review 9.  Tissue engineering of urinary bladder and urethra: advances from bench to patients.

Authors:  Hazem Orabi; Sara Bouhout; Amélie Morissette; Alexandre Rousseau; Stéphane Chabaud; Stéphane Bolduc
Journal:  ScientificWorldJournal       Date:  2013-12-24

10.  The role of Nesbit's procedure in surgical reconstruction of penile deviation.

Authors:  Christian Martenstein; Julia Peruth; Amir Hamza
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2012-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.